Acromegaly and pituitary gigantism
ICD-10 E22.0 is a billable code used to indicate a diagnosis of acromegaly and pituitary gigantism.
Acromegaly is a hormonal disorder that results from excess growth hormone (GH) in the body, typically due to a benign tumor on the pituitary gland known as an adenoma. This condition leads to the enlargement of bones and tissues, particularly in the face, hands, and feet. Patients may experience a range of symptoms including joint pain, thickened skin, and increased sweating. Pituitary gigantism, on the other hand, occurs in children and adolescents before the closure of growth plates, resulting in excessive height and growth. Both conditions are linked to dysregulation of the endocrine system, particularly involving the pituitary gland, which plays a crucial role in hormone production and regulation. The overproduction of GH can also lead to secondary complications such as diabetes mellitus, hypertension, and cardiovascular disease. Diagnosis typically involves measuring serum GH levels and conducting imaging studies like MRI to identify pituitary tumors. Treatment options may include surgical removal of the tumor, medication to inhibit GH production, or radiation therapy.
Detailed patient history, lab results, imaging studies, and treatment plans.
Diagnosis and management of acromegaly, monitoring of growth hormone levels, and treatment of associated conditions.
Endocrinologists must ensure comprehensive documentation of hormone levels and symptoms to support the diagnosis.
Operative reports, pre-operative assessments, and post-operative follow-ups.
Surgical intervention for pituitary adenomas causing acromegaly.
Surgeons should document the extent of tumor removal and any complications to support coding.
Used in cases where surgical intervention is required for pituitary adenomas causing acromegaly.
Operative report detailing the procedure and findings.
Endocrinologists and neurosurgeons must collaborate on documentation to ensure accurate coding.
Common symptoms include enlarged hands and feet, facial changes, joint pain, and increased sweating. Patients may also experience complications such as diabetes and hypertension.
